Should a Pill be Color Blind? The genetics of race, medicine, and drugs.
| View Part 2
Although accumulating population genetic data overwhelmingly supports the notion that "race" is a biologically meaningless concept, we have been unable to move beyond racial categorization in science, medicine and society. Partially responsible for our continued obsession with race is the fact that, although we do not have distinct biological types of "races," we do have geographical differences in the frequencies of genetic markers. These differences, no matter how infrequent they may be in comparison to observed similarities, are sometimes used to justify the social construct of race.

It is important to point out that geneticists have never found a genetic marker that is of one type in all the members of one large group and of a different type in all the members of another large group. Given this apparent imprecise nature of our socially defined racial groups, what then is the basis for some scientists to advocate for the development of drugs along color lines? This presentation will review current population genetic and pharmacogenomic data to show the hazards of using group labels like "African American" or "Hispanics" in the treatment of individual patients.